A number of other equities research analysts have also weighed in on the company. Morgan Stanley lifted their price objective on Metlife from $52.00 to $53.00 and gave the company an equal weight rating in a report on Wednesday, July 10th. Barclays lifted their price objective on Metlife from $52.00 to $55.00 and gave the company an overweight rating in a report on Wednesday, May 22nd. Citigroup set a $42.00 price objective on Metlife and gave the company a sell rating in a report on Thursday, May 23rd. UBS Group lifted their price objective on Metlife from $45.00 to $48.00 and gave the company a neutral rating in a report on Tuesday, April 9th. Finally, Deutsche Bank lifted their price objective on Metlife from $46.00 to $47.00 and gave the company a hold rating in a report on Friday, April 12th. Two equities research analysts have rated the stock with a sell rating, five have given a hold rating and six have issued a buy rating to the stock. The stock presently has a consensus rating of Hold and an average target price of $50.91.
MET traded down $1.04 during trading on Thursday, reaching $47.29. The company’s stock had a trading volume of 9,084,518 shares, compared to its average volume of 4,049,191. Metlife has a 52-week low of $37.76 and a 52-week high of $51.16. The firm has a fifty day moving average of $49.75. The company has a market capitalization of $45.93 billion, a P/E ratio of 8.77, a price-to-earnings-growth ratio of 1.05 and a beta of 1.09. The company has a debt-to-equity ratio of 0.22, a current ratio of 0.14 and a quick ratio of 0.14.
The company also recently declared a quarterly dividend, which will be paid on Friday, September 13th. Stockholders of record on Tuesday, August 6th will be paid a dividend of $0.44 per share. This represents a $1.76 annualized dividend and a dividend yield of 3.72%. The ex-dividend date is Monday, August 5th. Metlife’s dividend payout ratio (DPR) is 32.65%.
Large investors have recently made changes to their positions in the company. Kavar Capital Partners LLC purchased a new stake in shares of Metlife during the 2nd quarter worth approximately $25,000. Osborn Williams & Donohoe LLC purchased a new stake in shares of Metlife during the 1st quarter worth approximately $26,000. Advisory Alpha LLC purchased a new stake in shares of Metlife during the 1st quarter worth approximately $27,000. Jackson Grant Investment Advisers Inc. boosted its stake in shares of Metlife by 4,407.7% during the 1st quarter. Jackson Grant Investment Advisers Inc. now owns 586 shares of the financial services provider’s stock worth $25,000 after acquiring an additional 573 shares in the last quarter. Finally, Meridian Wealth Management LLC purchased a new stake in shares of Metlife during the 1st quarter worth approximately $26,000. 75.75% of the stock is currently owned by institutional investors and hedge funds.
MetLife, Inc engages in the insurance, annuities, employee benefits, and asset management businesses. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short- and long-term disability, individual disability, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and stable value products, including general and separate account guaranteed interest contracts, and private floating rate funding agreements.
Featured Article: What does it mean to hold a stock in street name?
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Metlife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Metlife and related companies with MarketBeat.com's FREE daily email newsletter.